The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Guardant Health (GH)
Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) is one of the 10 best robotics and automation stocks to invest in. On May 28, PROCEPT ...
The latest price target for PROCEPT BioRobotics (NASDAQ:PRCT) was reported by Truist Securities on December 18, 2025. The analyst firm set a price target for $47.00 expecting PRCT to rise to within 12 ...
Total revenue of $75.0 million for full year 2022, an increase of 118% compared to 2021 Total revenue of $23.8 million for the fourth quarter of 2022, an increase of 135% compared to the prior year ...
Shares of PROCEPT BioRobotics (PRCT) fell 8% on Thursday after Leerink Partnerscdowngraded the stock to Market Perform from Outperform and lowered its price target to $29 from $31, citing growing ...
SAN JOSE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...
Hosted on MSN
Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know
PROCEPT BioRobotics Corporation (PRCT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known ...
On Thursday, Spruce Point Capital released a detailed report on PROCEPT BioRobotics (NASDAQ:PRCT), raising concerns about the claims surrounding its market potential and growth prospects, suggesting ...
META: $214.48 million (5.3% of AUM) GOOGL: $171.23 million (4.2% of AUM) AMZN: $161.25 million (4.0% of AUM) NVDA: $149.51 million (3.7% of AUM) V: $137.50 million (3.4% of AUM) As of October 21, 2025 ...
Procept is a medical technology company offering a surgical procedure for benign prostatic hyperplasia (“BPH”), the enlargement of the prostate as a man ages, which can disrupt or block the urethra ...
REDWOOD SHORES, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics today announced the appointment of Kevin Waters as chief financial officer. Mr. Waters brings approximately 20 years of finance and medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results